Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Jae Wook Cho 2 Articles
Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Syndrome in a Korean Family
Minkyeong Kim, Seung Hwan Oh, Jae Wook Cho, Jae-Hyeok Lee
J Mov Disord. 2020;13(3):244-246.   Published online September 9, 2020
DOI: https://doi.org/10.14802/jmd.20064
  • 4,080 View
  • 75 Download
  • 1 Citations
PDF

Citations

Citations to this article as recorded by  
  • A Review of Ocular Movement Abnormalities in Hereditary Cerebellar Ataxias
    Mehri Salari, Masoud Etemadifar, Ronak Rashedi, Sayna Mardani
    The Cerebellum.2023;[Epub]     CrossRef
Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
Jae Wook Cho, Jae Hyeok Lee
J Mov Disord. 2014;7(1):28-30.   Published online April 30, 2014
DOI: https://doi.org/10.14802/jmd.14007
  • 10,261 View
  • 101 Download
  • 10 Citations
AbstractAbstract PDF
Myoclonus in corticobasal degeneration (CBD) has often been associated with severe and difficult to treat disabilities. Levetiracetam is a new antiepileptic agent with antimyoclonic effects. Herein, we present a 72-year-old woman with clinically probable CBD and with spontaneous rhythmic myoclonus in the right foot, which was markedly ameliorated through treatment with levetiracetam. The effect of levetiracetam was associated with the decreased amplitude of enlarged cortical somatosensory evoked potentials. This result suggests that the antimyoclonic effect of levetiracetam might be mediated through the suppression of increased cortical excitability.

Citations

Citations to this article as recorded by  
  • Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies
    Abdullahi Alausa, Sunday Ogundepo, Barakat Olaleke, Rofiat Adeyemi, Mercy Olatinwo, Aminat Ismail
    Chinese Medicine.2021;[Epub]     CrossRef
  • Four-Repeat Tauopathies: Current Management and Future Treatments
    Lawren VandeVrede, Peter A. Ljubenkov, Julio C. Rojas, Ariane E. Welch, Adam L. Boxer
    Neurotherapeutics.2020; 17(4): 1563.     CrossRef
  • Physiology-Based Treatment of Myoclonus
    Ashley B. Pena, John N. Caviness
    Neurotherapeutics.2020; 17(4): 1665.     CrossRef
  • Pharmacological interventions in corticobasal degeneration: a review
    Leonardo Caixeta, Victor de Melo Caixeta, Yanley Lucio Nogueira, Tales Alexandre Aversi-Ferreira
    Dementia & Neuropsychologia.2020; 14(3): 243.     CrossRef
  • Available and future treatments for atypical parkinsonism. A systematic review
    Davide Vito Moretti
    CNS Neuroscience & Therapeutics.2019; 25(2): 159.     CrossRef
  • An Update on Myoclonus Management
    Christine M. Stahl, Steven J. Frucht
    Expert Review of Neurotherapeutics.2019; 19(4): 325.     CrossRef
  • Corticobasal degeneration: key emerging issues
    F. Ali, K. A. Josephs
    Journal of Neurology.2018; 265(2): 439.     CrossRef
  • Focal Predominant Forms of Posthypoxic Action Myoclonus
    Carmen Gasca‚ÄźSalas, Anthony E. Lang
    Movement Disorders Clinical Practice.2016; 3(4): 417.     CrossRef
  • Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
    Ruth Lamb, Jonathan D. Rohrer, Andrew J. Lees, Huw R. Morris
    Current Treatment Options in Neurology.2016;[Epub]     CrossRef
  • An Update and Review of the Treatment of Myoclonus
    Kelly Mills, Zoltan Mari
    Current Neurology and Neuroscience Reports.2015;[Epub]     CrossRef

JMD : Journal of Movement Disorders